APVO Aptevo Therapeutics Inc.
$1.82▼ -0.55%
Healthcare
Other
After hours
$1.86▲ +2.20%
Sep 11, 7:30 PM ET
Volume 42.8K
Avg Volume (10D) 337.6K
Key Metrics & Fundamentals
Market Cap
$3.29M
P/E Ratio
0.0
Div Yield
–%
52W Range
1.37 - 48.78
% vs 50 MA
-47.72%
% vs 200 MA
-74.08%
RSI-14
27.8
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.26
Free Cash Flow
-$5.45M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$6.41M
COGS
–
Operating Exp
$6.44M
Operating Income
-$6.44M
EBIT
-$6.44M
Pretax Income
-$6.36M
Net Income
-$6.36M
EPS (Diluted)
-5.31
Price & Volume History
Loading chart…
Recent News
Aptevo Reports 93% Clinical Benefit Rate for Mipletamig Triplet in TP53-Mutated AML
InvestorsHub · Sep 3, 2026 2:19 PM
Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML
ACCESS Newswire · Sep 3, 2026 12:05 PM
APVO: Focusing on Three Key Areas of Development
Zacks Small Cap Research · Aug 24, 2026 9:02 AM
Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results
ACCESS Newswire · Aug 14, 2026 12:05 PM
Aptevo Therapeutics Announces Closing of Existing Warrants Exercise and PIPE for $4.5 Million Gross Proceeds
ACCESS Newswire · Aug 13, 2026 8:05 PM
Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds
ACCESS Newswire · Aug 12, 2026 1:30 PM
Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone
ACCESS Newswire · Jul 27, 2026 12:05 PM
Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors
ACCESS Newswire · Jun 30, 2026 12:05 PM
APVO: Initiating Coverage of Aptevo Therapeutics Inc.; Unlocking the Next Generation of Multispecific Immune Engagement
Zacks Small Cap Research · Jun 16, 2026 9:15 AM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See APVO's money flow as a full page
Social Sentiment
No Reddit posts found for APVO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.